MelliCell

NEWTON, MA · Biotechnology · 50 employees

MelliCell develops therapeutics for diabetes and obesity using proprietary technologies that model of weight gain in human fat cells in vitro. Our core technology enables discovery of therapeutic targets and leads, while reducing the time and money required for efficacy screening. It efficiently turns human stem cells into fat cells and accelerates their growth to sizes that are thousands of times

See plans & pricing → Track MelliCell’s funding, hiring, and signals — with verified contacts — on Fundz.